Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Online Inspection during Injectable Manufacturing – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Online Inspection during Injectable Manufacturing – V 2.0

Standard Operating Procedure for Online Inspection during Injectable Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/038/2025
Supersedes SOP/SIM/038/2022
Page No. Page 1 of 13
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

This SOP outlines the procedure for online inspection of injectable products during manufacturing to ensure quality, accuracy, and compliance with GMP guidelines. The goal is to detect any defects or deviations in real time and take corrective actions immediately.

2. Scope

This procedure applies to the online inspection of vials, ampoules, and prefilled syringes during filling, sealing, and labeling operations within the sterile manufacturing facility.

3. Responsibilities

  • Operators: Perform continuous inspection and report abnormalities during manufacturing.
  • In-Process QA: Monitors compliance with inspection protocols and documents observations.
  • Production Supervisor: Ensures inspection stations are manned and defects are segregated.
  • Engineering: Maintains inspection lighting and conveyor functionality.
See also  Sterile Injectable Manufacturing: SOP for Sterility Testing of Injectable Products - V 2.0

4. Accountability

The Head of Production is accountable for implementing and enforcing online inspection procedures and ensuring timely resolution of any quality deviations observed during the process.

5. Procedure

5.1 Inspection Setup

  1. Ensure that visual inspection areas are equipped with:
    • Proper lighting (5000 to 5400 Lux)
    • Black and white background screens
    • Turntables or conveyor belts (if applicable)
  2. Clean the inspection area before batch startup and record in the Cleaning Log.
  3. Verify batch details and affix appropriate product labels at inspection points.

5.2 Types of Inspections

  1. Visual Inspection for Particulate Matter: Observe the product against light for visible particles.
  2. Seal Integrity Check: Confirm the integrity of rubber stoppers, crimping, or syringe closures.
  3. Fill Volume Check: Verify fill volume using reference standards at defined intervals.
  4. Label Verification: Ensure correct labeling, alignment, and legibility.

5.3 Frequency and Sampling

  1. Inspect every unit manually or via automated camera-based systems, as per equipment capabilities.
  2. Sample every 15 minutes for fill volume and sealing defects using random samples (Annexure-1).
  3. QA to cross-verify 1% of inspected lots hourly and record results (Annexure-2).
See also  Quality Assurance: SOP for Preparing Annual Product Quality Review (APQR) Reports - V 2.0

5.4 Defect Classification

  1. Critical: Particulate matter, wrong product, missing closure.
  2. Major: Improper fill volume, loose seals, mislabeling.
  3. Minor: Aesthetic issues, slight label skew.
  4. Segregate defective products in a red-labeled container and record in Defect Log (Annexure-3).

5.5 Action on Rejection

  1. QA must evaluate high defect rates (≥ 1% in 30-minute interval) and initiate deviation report.
  2. All affected containers must be quarantined and assessed for potential reinspection or rejection.
  3. Root cause analysis and CAPA shall be initiated as per QA guidelines.

5.6 Documentation

  1. Complete the Online Inspection Log for each shift and batch.
  2. Defect summary shall be included in Batch Manufacturing Record (BMR).
  3. Maintain inspection logs for a minimum of 5 years.

6. Abbreviations

  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action
  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record

7. Documents

  1. Inspection Checklist – Annexure-1
  2. QA Verification Record – Annexure-2
  3. Defect Log Sheet – Annexure-3
See also  Sterile Injectable Manufacturing: SOP for Monitoring Batch Yield during Injectable Production - V 2.0

8. References

  • WHO TRS 961 Annex 6
  • EU GMP Annex 1: Manufacture of Sterile Medicinal Products
  • ICH Q8 (R2) – Pharmaceutical Development

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Inspection Checklist

Date Time Batch No. Defect Type Units Checked Units Rejected Inspected By
18/06/2025 10:30 IM-2205 Particulate 100 2 Rajesh Kumar

Annexure-2: QA Verification Record

Time Checked Units Findings QA Signature
11:00 50 No Defects Neha Sharma

Annexure-3: Defect Log Sheet

Date Batch No. Defect Type No. of Units Disposition Remarks
18/06/2025 IM-2205 Loose Seal 3 Rejected Line recalibrated

Revision History

Revision Date Revision No. Details Reason Approved By
12/01/2022 1.0 Initial version New SOP QA Head
18/06/2025 2.0 Added Annexures and inspection frequency table Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Gel Manufacturing: SOP for Reporting Quality Control Results for Gels – V 2.0
Next Post: API Manufacturing: SOP for Market Complaint Trending and Evaluation – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version